UNSPSC 51384703: Isamfazone

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C22H23N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XUW8L8PW09, chemically known as 1(6h)-pyridazineacetamide, n-methyl-n-alpha-methylphenethyl-6-oxo-3-phenyl-, l- but generally known as isamfazone, which bears US NIH Compound Identifier 68753. European Medicines Agency schedules Isamfazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08303MIG.

UNSPSC 51384703 Isamfazone is a Commodity code that does not reflect the actual scope of recent state and local procurement activity. The three recent opportunities posted under this code solicit naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and over-the-counter products—none of which are isamfazone. The mismatch between the code's nominal scope and the work actually being bought suggests either a systematic miscoding issue or category drift in the issuing agencies' procurement systems. State and local governments appear to be using this code to classify opioid-reversal and broader pharmaceutical procurement, including both standalone naloxone acquisition and participation in cooperative pharmaceutical purchasing arrangements.

Recent activity includes issuing bodies across the health and human services sector: Seminole County, Florida (a county health department), the Texas Health and Human Services Commission (a state agency), and the Minnesota Multistate Cooperative Purchasing Alliance (a cooperative purchasing vehicle spanning multiple states including Oregon). Seminole County issued an IFB for 1,900 units of naloxone and 800 safe drug deactivation systems with a response deadline of July 26, 2023; Texas HHS issued an RFI in April 2026 to explore direct-to-manufacturer prescription models; and MMCAP issued an RFP in January 2026 for generic pharmaceuticals and OTC products available through three authorized wholesalers with a March 26, 2026 deadline. Geographic activity centers on Florida and Texas, with cooperative participation extending to Oregon and other MMCAP member jurisdictions. The code shows mixed activity across county health departments, state health agencies, and multi-state cooperative programs, but the mismatch between code name and actual procurement scope limits confidence in trend interpretation under this specific commodity classification.